Related Experiment Video

Updated: Jul 19, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Diverse functions of p120ctn in tumors

Jolanda van Hengel1, Frans van Roy

  • 1Molecular Cell Biology Unit, Department for Molecular Biomedical Research, VIB-Ghent University, Technologiepark 927, B-9052 Gent (Zwijnaarde), Belgium.

Biochimica Et Biophysica Acta
|October 13, 2006
PubMed

Insights

p120catenin (p120ctn) protein plays roles in cell adhesion and signaling. Its altered expression and localization are linked to human tumor progression, but causal links require further investigation.

Area of Science:

  • Molecular and Cellular Biology
  • Cancer Research
  • Protein Biochemistry

Background:

  • p120catenin (p120ctn) is an Armadillo family protein crucial for stabilizing the cadherin-catenin adhesion complex at the plasma membrane.
  • Beyond cell adhesion, p120ctn exhibits diverse functions in the cytoplasm and nucleus.
  • Alternative mRNA splicing and phosphorylation create multiple p120ctn isoforms, adding functional complexity.

Purpose of the Study:

  • To review the emerging evidence linking p120ctn to human tumor progression.
  • To explore the potential roles of specific p120ctn isoforms, localization, and phosphorylation in cancer prognosis.
  • To identify knowledge gaps regarding the causal relationship between p120ctn alterations and tumor outcomes.

Main Methods:

  • Literature review and synthesis of existing research on p120ctn.
  • Analysis of studies correlating p120ctn expression, localization, and phosphorylation with tumor characteristics.
  • Identification of key questions for future experimental validation.

Main Results:

  • Loss, downregulation, or mislocalization of p120ctn is frequently observed in various human cancers.
  • These alterations correlate with tumor progression, suggesting a role in cancer development.
  • The specific contribution of different p120ctn isoforms and post-translational modifications to cancer remains largely uncharacterized.

Conclusions:

  • p120ctn is implicated in human tumor progression through mechanisms potentially involving altered expression, localization, and specific isoforms.
  • Further research is needed to establish a causal link between p120ctn characteristics and tumor prognosis.
  • Investigating specific p120ctn isoforms and their subcellular localization is critical for understanding their role in cancer.

Related Concept Videos

Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...